Movies on Netflix are like Houdini's props. One moment they're there, the next moment they aren't. Check out these horror movies before they leave.

US FDA grants orphan drug designation to Klotho Neurosciences’ KLTO-202 to treat amyotrophic lateral sclerosis: New York Saturday, July 12, 2025, 15:00 Hrs [IST] Klotho Neurosci ...

In a powerful act of compassion and community, Starr’s Mill High School organized an early graduation for rising senior ...

As a result of being afflicted with PLS, he is unable to walk and is dependent on a caregiver for help with his daily needs.

A coalition of ALS patients and caregivers is petitioning the FDA to review available data on the stem cell therapy NurOwn ...

Stem cell tech simulates ALS, quantum tools decode quasicrystals, and cancer exploits a human mutation—three breakthroughs ...

Purpose Amyotrophic lateral sclerosis (ALS) presents with varying degrees of brain degeneration that can extend beyond the corticospinal tract (CST). Furthermore, the clinical course and progression ...

Neurizon Therapeutics has announced it has received positive feedback from the US Food and Drug Administration (FDA) on its ...

Klotho Neurosciences ( ($KLTO) ) has provided an announcement. On July 10, 2025, Klotho Neurosciences announced that the FDA granted Orphan Drug ...

Documenting his experiences has proven to be the outlet Darin Nakakihara needs in the wake of his ALS diagnosis.

The U.S. FDA has granted orphan drug designation to Klotho Neurosciences Inc.’s secreted-Klotho (s-KL) promoter, gene and ...

Doctors implanted a microchip into a paralyzed patient's brain as part of a clinical trial giving people the ability to ...